fromIPWatchdog.com | Patents & Intellectual Property Law
10 hours ago10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents
On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, Inc. in the United States District Court for the District of Delaware, asserting that Illumina's spatial technology products infringed on patents covering technology for spatial transcriptomics, which allows researchers to study gene activity within a cell's tissue. U.S. Patent Nos. 11,008,607, 11,549,138, 12,234,505, and 12,297,487 are owned by Prognosys Biosciences and have significant applications in cancer research, neuroscience and immunology.
Science